Abpro Holdings (ABPO) Change in Account Payables (2024 - 2026)
Abpro Holdings' (ABPO) quarterly Change in Account Payables came in at -$371000.0 in Q1 2026, down 148.31% YoY from $768000.0 in Q1 2025, and down 180.65% on a QoQ basis from $460000.0 in Q4 2025.
Abpro Holdings (ABPO) Change in Account Payables (2024 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 3 years of Change in Account Payables data on file, last reported at -$371000.0 in Q1 2026.
- Quarterly Change in Account Payables fell 148.31% year-over-year to -$371000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $108000.0 (down 66.87% YoY) and the FY2025 annual result came in at $1.2 million, up 245.0% from the prior year.
- Change in Account Payables fell to -$371000.0 in Q1 2026, from $460000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $768000.0 in Q1 2025 to a low of -$1.2 million in Q4 2024.
- A 3-year average of $1777.8 and a median of $364000.0 in 2024 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 283.73% in 2025, down 248.63% in 2025.
- Tracing ABPO's Change in Account Payables over 3 years: stood at -$1.2 million in 2024, then jumped by 138.82% to $460000.0 in 2025, then plunged by 180.65% to -$371000.0 in 2026.
- The last three Change in Account Payables figures came in at -$371000.0 (Q1 2026), $460000.0 (Q4 2025), and -$541000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | -574,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -371,000.00 |
| Mar 31, 2026 | -371,000.00 |
| Dec 31, 2025 | 460,000.00 |
| Dec 31, 2025 | 460,000.00 |
| Sep 30, 2025 | -541,000.00 |
| Sep 30, 2025 | -541,000.00 |
| Jun 30, 2025 | 560,000.00 |
| Jun 30, 2025 | 560,000.00 |
| Mar 31, 2025 | 768,000.00 |
| Mar 31, 2025 | 768,000.00 |
| Dec 31, 2024 | -1.19 Mn |
| Dec 31, 2024 | -1.19 Mn |
| Sep 30, 2024 | 364,000.00 |
| Sep 30, 2024 | 364,000.00 |
| Jun 30, 2024 | 379,000.00 |
| Jun 30, 2024 | 379,000.00 |
| Mar 31, 2024 | -418,000.00 |
| Mar 31, 2024 | -418,000.00 |